MENU
+Compare
VIR
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$5.16
Change
-$0.12 (-2.27%)
Capitalization
729.9M

VIR Vir Biotechnology Forecast, Technical & Fundamental Analysis

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more

VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VIR with price predictions
Jun 04, 2025

VIR's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for VIR moved out of oversold territory on May 27, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on VIR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VIR just turned positive on May 28, 2025. Looking at past instances where VIR's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VIR advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

VIR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VIR entered a downward trend on May 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.699) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). VIR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (50.505) is also within normal values, averaging (265.014).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VIR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VIR is expected to report earnings to fall 11.89% to -77 cents per share on July 31

Vir Biotechnology VIR Stock Earnings Reports
Q2'25
Est.
$-0.78
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.51
Q2'24
Missed
by $0.13
The last earnings report on May 07 showed earnings per share of -87 cents, missing the estimate of -87 cents. With 494.57K shares outstanding, the current market capitalization sits at 729.90M.
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPFX9.120.05
+0.51%
Invesco SteelPath MLP Select 40 A
PFSVX13.18N/A
N/A
iMGP Small Company Fund Instl Cl
BIICX10.29N/A
N/A
BlackRock Multi-Asset Income Instl
FSHOX116.62N/A
N/A
Fidelity Select Construction & Housing
JHACX9.81N/A
N/A
JHancock Multi-Asset Absolute Return C

VIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+0.96%
SANA - VIR
63%
Loosely correlated
-0.85%
AXON - VIR
47%
Loosely correlated
+2.76%
CPRX - VIR
45%
Loosely correlated
+1.53%
GOSS - VIR
41%
Loosely correlated
+3.28%
IMNM - VIR
41%
Loosely correlated
-2.59%
More